-
Alexion’s Quest To Test The Algorithm Of Rare Disease Diagnosis
Jun 20, 2018, 09:40 AM by Michael CroftFull storyBio-IT World | Alexion, in collaboration with EPAM, has developed a software competition platform to allow the objective comparison of contributed algorithms for automated rare disease diagnosis.
-
Sartorius Stedim Biotech and Siemens sign long-term cooperation agreement in the area of automation
Jun 20, 2018, 09:37 AM by Michael Croft, GERMANY - Jun 20, 2018 - • Siemens becomes a preferred supplier for automation solutions • Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future • New automated product to debut at the ACHEMA 2018 trade show in Frankfurt Göttingen | Munich - The Siemens technology group and Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automationFull story -
Creative Biolabs Will Continue to Enrich the Phage Display Library Service Items
Jun 19, 2018, 22:37 PM by Michael CroftSHIRLEY, NY - Jun 19, 2018 - June 19, 2018, with the commitment of deliver the highest quality results and rich service items to our clients with speed, Creative Biolabs is going to enrich its phage display library which is recognized as the most powerful and widely used technique for the study of protein-protein, protein-DNA and protein-peptides interactionsFull story -
Greenphire Partners with Lyft to Support Clinical Trial Patient Retention and Access
Jun 19, 2018, 12:21 PM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Jun 19, 2018 - Greenphire, the global leader in financial software for clinical trials, today announced it has partnered with Lyft, to deliver a seamless experience for site coordinators to book a ride and execute a reimbursement or stipend for clinical trial participants within its industry-leading ClinCard solutionFull story -
Creative Diagnostics Continues to Expand Its Offering with New Nanoclusters
Jun 19, 2018, 10:48 AM by Michael CroftSHIRLEY - Jun 19, 2018 - With years of experience in the pharmaceutical and life science sector, Creative Diagnostics recently launches Nanclusters, which are functionalized with carboxyl groups that allow the covalent conjugation of antibodies by formation of stable amide bonds with primary aminesFull story -
LBRN Summer Bioinformatics Training Program
Jun 19, 2018, 10:39 AM by Michael CroftNEW ORLEANS, LA, UNITED STATES - Jun 19, 2018 - Pine Biotech and Louisiana Biomedical Research Network (LBRN) announce the registration for its upcoming Louisiana Biomedical Research Network Summer Bioinformatics Training Program which starts June 6 continue through August 15, 2018Full story -
Roche Pays $2.4 Billion For Rest Of Cancer Expert Foundation Medicine
Jun 19, 2018, 09:42 AM by Michael CroftReuters | Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine, raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.Full story -
Peerwith extends equity crowdfunding opportunity to the public
Jun 19, 2018, 09:35 AM by Michael CroftAMSTERDAM, NETHERLANDS - Jun 19, 2018 - Peerwith, the peer-to-peer marketplace for scientists, is opening the next phase of its equity crowdfunding campaign to extend the offering to the publicFull story -
Enamine and TBD Biodiscovery collaborate to provide GMP-based services
Jun 19, 2018, 05:37 AM by Michael Croft, UKRAINE - Jun 19, 2018 - Enamine Ltd., a chemical research organization and producer of novel building blocks and screening libraries, and TBD Biodiscovery, a premium GMP manufacturer of fine chemicals including chemical active pharmaceutical ingredients (APIs), today announced they have entered into a collaboration agreementFull story -
Optibrium Introduces StarDrop 6.5
Jun 19, 2018, 05:33 AM by Michael Croft, UK - Jun 19, 2018 - Optibrium, a developer of software for drug discovery, today announced the launch of version 6.5 of StarDrop that provides a complete platform for small molecule design, optimisation and data analysisFull story -
Protein Dynamic Solutions establishes new headquarters and operations in Massachusetts
Jun 19, 2018, 02:25 AM by Michael CroftWAKEFIELD, MA - Jun 19, 2018 - Protein Dynamic Solutions LLC (PDS), developer of platforms for biopharmaceutical critical quality attribute (CQA) and biosimilar assessment,has recently established a new head office, as well as research and operations, in Wakefield, MassachusettsFull story -
Celgene’s LabAlert System Focuses On Scientific Workflow Efficiency, User Experience
Jun 18, 2018, 14:00 PM by Michael CroftFull storyBio-IT World | Innovative mobile technology that quickly sends warnings and error notifications to users’ mobile devices won a Bio-IT World 2018 Best Practices Award. The Celgene Lab Instrument Mobile Alert (LabAlert) system integrates into the laboratory environment to generate, manage, and report real-time alerts from lab instruments to mobile devices.
-
Thermo Fisher Scientific Expands RNA Cells-to-CT Kits
Jun 18, 2018, 11:37 AM by Michael CroftCARLSBAD, CA, UNITED STATES - Jun 18, 2018 - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new Invitrogen TaqMan & SYBR Green Fast Advanced Cells-to-CT Kits, further strengthening its line of RNA Cells-to-CT productsFull story -
Record growth at Sterling Pharma Solutions
Jun 18, 2018, 08:35 AM by Michael CroftCRAMLINGTON, UK - Jun 18, 2018 - A UK-based contract development and manufacturing organisation (CDMO) has more than doubled its sales since its formation in 2016 as demand for its hazardous chemistry capabilities and active pharmaceutical ingredient (API) services growsFull story -
Clinical excellence in One Stop pathway audit data presented at Association of Breast Surgery Conference
Jun 18, 2018, 06:19 AM by Michael CroftCAMBRIDGE, UK - Jun 18, 2018 - Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, presents audit results from its private breast cancer diagnosis pathway to the Association of Breast Surgery annual conference in Birmingham todayFull story -
Check4Cancer wins Diagnostics Provider of the Year at the 2018 Health Investor Awards
Jun 15, 2018, 04:55 AM by Michael CroftLONDON, UK - Jun 15, 2018 - Check4Cancer is delighted to announce it has been awarded Diagnostics provider of the year at the 2018 Health Investor Awards held at the Grosvenor Hotel, LondonFull story -
ZEISS presents new enhanced software technology
Jun 14, 2018, 14:37 PM by Michael CroftBOSTON, MA, UNITED STATES - Jun 14, 2018 - ZEISS presents new enhanced software technologyZEISS ZEN Connect provides information from all dimensions of a sampleJENA/GermanyFull story
ZEISS introduces new software modules with enhanced imaging technology: ZEISS ZEN Connect is especially useful for, but not limited to, structural analysis, examination of cellular processes, localization of cells, and much more -
Certara Supports the Not-for-profit Biotechnology Company Medicines Development for Global Health (MDGH) on the FDA New Drug Approval of Moxidectin for the Treatment of River Blindness (Onchocerciasis
Jun 14, 2018, 09:07 AM by Michael CroftPRINCETON, NJ - Jun 14, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today celebrated an important milestone for its public health drug development and treatment consulting portfolioFull story -
TECHNIDATA implements its TDNexlabs LIS in a hosted-mode for the computerization of the French Epinal-Remiremont hospital group multi-site laboratories.
Jun 14, 2018, 08:47 AM by Michael CroftMONTBONNOT, FRANCE - Jun 5, 2018 - A successful project that now enables an effective management of laboratories in both healthcare facilities with a single system and an outsourced infrastructurexFull story -
Benchling Raises $14.5M From Benchmark To Advance Life Sciences Research
Jun 14, 2018, 08:40 AM by Michael CroftFull storyBio-IT World Brief | Today Benchling announced it has closed $14.5M in Series B funding led by Benchmark, with participation from F-Prime Capital and returning investor Thrive Capital.